Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nadarzyn

36 clinical trials in Nadarzyn, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nadarzyn at a glance
36
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

36 trials in Nadarzyn

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VENT-03
  • Sponsor:Ventus Therapeutics U.S. Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cytisine
  • Sponsor:University of Rzeszow
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Teplizumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International

Psoriatic arthropathy

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Psoriasis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Rheumatoid arthritis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nadarzyn

What the registry says about research in the country

01 Rheumatoid Arthritis Research

Multiple clinical trials focusing on rheumatoid arthritis treatments, including studies of novel biosimilars and combination therapies. Research aims to evaluate the effectiveness of new medications in reducing disease symptoms and improving patient outcomes.

  • Advanced therapy combinations
  • Biosimilar evaluations
  • Early intervention studies
02 Psoriatic Disease Studies

Comprehensive research into psoriatic arthritis and plaque psoriasis, investigating new biological treatments and their efficacy in managing symptoms. Studies include both biologic-naïve and experienced patients.

  • Novel therapeutic agents
  • Long-term safety assessments
  • Comparative efficacy studies
03 Autoimmune Conditions

Innovative research targeting various autoimmune conditions, including Sjögren's Disease and Systemic Lupus Erythematosus. Studies focus on evaluating new treatment approaches and disease activity measures.

  • Disease-modifying therapies
  • Novel treatment pathways
  • Long-term disease management
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.